1. Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial. Issue 4 (April 2019) Authors: Priddy, Frances H; Lewis, David J M; Gelderblom, Huub C; Hassanin, Hana; Streatfield, Claire; LaBranche, Celia; Hare, Jonathan; Cox, Josephine H; Dally, Len; Bendel, Daryl; Montefiori, David; Sayeed, Eddy; Ackland, Jim; Gilmour, Jill; Schnepp, Bruce C; Wright, J Fraser; Johnson, Philip Journal: Lancet Issue: Volume 6:Issue 4(2019) Page Start: e230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2. (February 2023) Authors: Szubert, Alex J.; Pollock, Katrina M.; Cheeseman, Hannah M.; Alagaratnam, Jasmini; Bern, Henry; Bird, Olivia; Boffito, Marta; Byrne, Ruth; Cole, Tom; Cosgrove, Catherine A.; Faust, Saul N.; Fidler, Sarah; Galiza, Eva; Hassanin, Hana; Kalyan, Mohini; Libri, Vincenzo; McFarlane, Leon R.; Milinkovic... Journal: EClinicalMedicine Issue: Volume 56(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial. Issue 12 (December 2022) Authors: Lazarus, Rajeka; Querton, Benedicte; Corbic Ramljak, Irena; Dewasthaly, Shailesh; Jaramillo, Juan Carlos; Dubischar, Katrin; Krammer, Michael; Weisova, Petronela; Hochreiter, Romana; Eder-Lingelbach, Susanne; Taucher, Christian; Finn, Adam; Bethune, Claire; Boffito, Marta; Bula, Marcin; Burns, Fi... Journal: Lancet infectious diseases Issue: Volume 22:Issue 12(2022) Page Start: 1716 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial. (February 2022) Authors: Pollock, Katrina M.; Cheeseman, Hannah M.; Szubert, Alexander J.; Libri, Vincenzo; Boffito, Marta; Owen, David; Bern, Henry; O'Hara, Jessica; McFarlane, Leon R.; Lemm, Nana-Marie; McKay, Paul F.; Rampling, Tommy; Yim, Yee Ting N.; Milinkovic, Ana; Kingsley, Cherry; Cole, Tom; Fagerbrink, Susanne;... Journal: EClinicalMedicine Issue: Volume 44(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial. (February 2022) Authors: Pollock, Katrina M.; Cheeseman, Hannah M.; Szubert, Alexander J.; Libri, Vincenzo; Boffito, Marta; Owen, David; Bern, Henry; McFarlane, Leon R.; O'Hara, Jessica; Lemm, Nana-Marie; McKay, Paul; Rampling, Tommy; Yim, Yee Ting N.; Milinkovic, Ana; Kingsley, Cherry; Cole, Tom; Fagerbrink, Susanne; Ab... Journal: EClinicalMedicine Issue: Volume 44(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗